[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-GTBP":3,"homepage-market-summary":31,"stock-news-GTBP":173},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"GTBP","2026-10-02",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"GT Biopharma Inc. Common Stock","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. The company is engaged in discovering, developing, and commercializing therapeutics from its proprietary product platform across various disease areas, mainly focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platform offers immuno-oncology products designed to treat hematologic malignancies, sarcoma, and solid tumors.","1","San Francisco, CA",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":22,"volume":23,"transactions":24,"vwap":25,"high_52w":26,"low_52w":27,"avg_volume_52w":28,"range_52w_percent":29,"record_count":30},6.1,6.36,6.51,6,6.2,-0.1,-1.61,62104.465102,981,6.2192,11.98,0.2524,1391430.845007432,49.9,2145,{"status":32,"indices":33,"watchlist":77,"sectors":99,"benchmarks":155},"success",[34,42,49,56,63,70],{"symbol":35,"name":36,"price":37,"change":38,"pct_change":39,"is_up":40,"sparkline":41,"date":5},"SPX","S&P 500",7722.72,56.27,0.73,true,"0.0,5.0 2.3,8.0 4.6,10.4 6.9,13.4 9.3,9.1 11.6,11.5 13.9,13.8 16.2,16.0 18.5,10.3 20.8,9.5 23.2,2.0 25.5,2.0 27.8,5.9 30.1,6.0 32.4,3.4 34.7,7.3 37.1,8.2 39.4,9.4 41.7,8.5 44.0,4.8",{"symbol":43,"name":44,"price":45,"change":46,"pct_change":47,"is_up":40,"sparkline":48,"date":5},"NDX","NASDAQ 100",30807.93,306.37,1,"0.0,11.5 2.3,11.7 4.6,12.4 6.9,14.8 9.3,12.8 11.6,14.6 13.9,16.0 16.2,15.9 18.5,12.2 20.8,10.7 23.2,4.4 25.5,2.6 27.8,4.5 30.1,4.5 32.4,3.5 34.7,6.0 37.1,5.5 39.4,5.0 41.7,4.3 44.0,2.0",{"symbol":50,"name":51,"price":52,"change":53,"pct_change":54,"is_up":40,"sparkline":55,"date":5},"DJI","DOW JONES",51177,250,0.49,"0.0,2.0 2.3,5.5 4.6,7.8 6.9,9.5 9.3,6.7 11.6,7.5 13.9,9.4 16.2,12.9 18.5,11.1 20.8,11.7 23.2,9.6 25.5,10.7 27.8,12.6 30.1,13.5 32.4,10.8 34.7,12.8 37.1,13.5 39.4,16.0 41.7,15.9 44.0,14.5",{"symbol":57,"name":58,"price":59,"change":60,"pct_change":61,"is_up":40,"sparkline":62,"date":5},"COMP","NASDAQ Composite",27190.86,319.27,1.19,"0.0,10.2 2.3,11.1 4.6,13.0 6.9,14.9 9.3,12.1 11.6,13.7 13.9,16.0 16.2,16.0 18.5,11.1 20.8,10.0 23.2,3.4 25.5,2.0 27.8,5.4 30.1,5.4 32.4,3.9 34.7,6.7 37.1,6.9 39.4,6.2 41.7,6.1 44.0,2.6",{"symbol":64,"name":65,"price":66,"change":67,"pct_change":68,"is_up":40,"sparkline":69,"date":5},"RUT","RUSSELL 2000",2815.2,25,0.9,"0.0,2.0 2.3,3.0 4.6,6.1 6.9,8.4 9.3,7.5 11.6,8.8 13.9,10.4 16.2,11.3 18.5,10.2 20.8,11.2 23.2,10.1 25.5,8.8 27.8,12.9 30.1,13.1 32.4,12.8 34.7,14.4 37.1,15.1 39.4,16.0 41.7,15.1 44.0,13.2",{"symbol":71,"name":72,"price":73,"change":74,"pct_change":75,"is_up":14,"sparkline":76,"date":5},"VIX","CBOE VIX",15.31,-1.08,-6.59,"0.0,14.8 2.3,10.2 4.6,7.3 6.9,2.0 9.3,9.7 11.6,4.9 13.9,4.5 16.2,2.5 18.5,11.3 20.8,13.7 23.2,13.5 25.5,16.0 27.8,12.3 30.1,10.4 32.4,13.5 34.7,8.8 37.1,8.9 39.4,7.8 41.7,7.6 44.0,11.8",[78,85,92],{"symbol":79,"name":80,"price":81,"change":82,"pct_change":83,"is_up":40,"sparkline":84,"date":5},"NVDA","NVIDIA Corp",233.95,3.09,1.34,"0.0,16.0 7.3,15.3 14.7,9.6 22.0,12.1 29.3,10.3 36.7,6.6 44.0,2.0",{"symbol":86,"name":87,"price":88,"change":89,"pct_change":90,"is_up":40,"sparkline":91,"date":5},"AAPL","Apple Inc",333.69,3.37,1.02,"0.0,8.2 7.3,2.0 14.7,5.2 22.0,16.0 29.3,11.7 36.7,14.9 44.0,10.9",{"symbol":93,"name":94,"price":95,"change":96,"pct_change":97,"is_up":40,"sparkline":98,"date":5},"TSLA","Tesla Inc",370.59,16.48,4.65,"0.0,2.0 7.3,5.3 14.7,13.4 22.0,16.0 29.3,14.9 36.7,15.3 44.0,6.1",[100,105,110,115,120,125,130,135,140,145,150],{"name":101,"etf":102,"change":103,"price":104,"is_up":40},"Technology","XLK",1.01,199.81,{"name":106,"etf":107,"change":108,"price":109,"is_up":40},"Financials","XLF",0.06,53.49,{"name":111,"etf":112,"change":113,"price":114,"is_up":14},"Healthcare","XLV",-0.01,166.18,{"name":116,"etf":117,"change":118,"price":119,"is_up":40},"Consumer Cycl","XLY",1.13,110.04,{"name":121,"etf":122,"change":123,"price":124,"is_up":40},"Consumer Staples","XLP",0.25,80.53,{"name":126,"etf":127,"change":128,"price":129,"is_up":40},"Energy","XLE",0.4,62.95,{"name":131,"etf":132,"change":133,"price":134,"is_up":40},"Industrials","XLI",0.78,169.95,{"name":136,"etf":137,"change":138,"price":139,"is_up":40},"Materials","XLB",0.66,48.86,{"name":141,"etf":142,"change":143,"price":144,"is_up":40},"Real Estate","XLRE",0.32,40.81,{"name":146,"etf":147,"change":148,"price":149,"is_up":40},"Utilities","XLU",0.38,39.83,{"name":151,"etf":152,"change":153,"price":154,"is_up":40},"Comm Services","XLC",0.35,110.32,[156,161,165,169],{"ticker":157,"name":158,"price":159,"change":160,"is_up":40},"SPY","SPDR S&P 500 ETF",769.64,0.74,{"ticker":162,"name":163,"price":164,"change":90,"is_up":40},"QQQ","Invesco QQQ Trust",749.58,{"ticker":166,"name":167,"price":168,"change":54,"is_up":40},"DIA","SPDR Dow Jones ETF",511.1,{"ticker":170,"name":171,"price":172,"change":68,"is_up":40},"IWM","iShares Russell 2000",281.52,{"ticker":4,"count":19,"articles":174},[175,181,187,193,199,204],{"title":176,"link":177,"pubDate":178,"description":179,"source":180},"With $31.2M left to sell, GT Biopharma (GTBP) has made its first equity sale. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMilgFBVV95cUxOakYyQnlBVXA1Q3hHUTU5VW1NeG15RXFndlQzZDRxR1N1dHE1bnZSMkE2ZlM2dWQyRDR1Nm1oR0QyaENyb1hLdGM3a3ZZdmY2aDVqdEZCNFdZU0UwRm9HN3ZlWkppVU9oekRPNHkwZnlzd2J5UXVlNy1tNGNuSHpndHB0ZWJYanJUdkwwWUM4M2VYdGZXc2c?oc=5","Tue, 29 Sep 2026 17:06:37 GMT","With $31.2M left to sell, GT Biopharma (GTBP) has made its first equity sale. Stock Titan","Stock Titan",{"title":182,"link":183,"pubDate":184,"description":185,"source":186},"GT Biopharma regains Nasdaq $1.00 minimum bid compliance after 10-day stretch - TradingView","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi1AFBVV95cUxQQjJDdkJNX3dGSG0yaUtsdVRJemlpTlpFaVo2ZjRCZ0VLQkJ3UmhpSS1ERzVVRzZwd3plMVg3MF9WbDdPVjhWUmlubWd3X2c0VFlyNEFNMFRaekNHR0pDREVTbk5SaEtaYVlVZkNEQ3Z3OGg1amJiR01XTHJHUEczQ2J6dktGOHo3dmEtcTMzS3FDcHNTNGRQN25kSzdKUGRGMGNkaEFUZ2tmQ3ZhMlBsbmpIMl91SkZoajZ1dUJaSFZ1MmlaQjJyaDhlUlVYX0xQVjBUUg?oc=5","Fri, 25 Sep 2026 20:13:10 GMT","GT Biopharma regains Nasdaq $1.00 minimum bid compliance after 10-day stretch TradingView","TradingView",{"title":188,"link":189,"pubDate":190,"description":191,"source":192},"GT Biopharma Expands Series M Preferred Financing Agreement - TipRanks","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMisAFBVV95cUxQSmFqTFp4WWtlUUk4WE9wRFphOW9hUEROUV9hOGkybGhiS2R2VExTb2ZhVGt4NVJHbm1WWm9OMklPY3FQSWQ2NWpzMDJYbDR3djhJT2dpMHlRcGJKemhNVDVqRzhBZ2RaRld3SlVEZWYzTFdOZWJ6d2xnWjVtbGdwNUxlQy1PbWtoaUxXakpoVTNSMWl2NjRHNEpsWUo1di1Ta3lfTDhuWnptaVAzSV9ITQ?oc=5","Sat, 26 Sep 2026 23:49:57 GMT","GT Biopharma Expands Series M Preferred Financing Agreement TipRanks","TipRanks",{"title":194,"link":195,"pubDate":196,"description":197,"source":198},"GT Biopharma sells USD 7.75 million: what it means for GT Biopharma stock - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiywFBVV95cUxNMmZPVTFhNUZkNERtYlUxMFRlaktiTWpaUllFWHkzZ0hOYlFyTzNHVUhCZ1JHXzNWbnJnVWxqdkpqVzJlN1g0bERZa001dUZ4enFJMEFzSWx5WVdlSjBJOUk5V0VpeXdXSlk3R0JNSlJTZFE1cWRPejJXS1c3d3cwV2VjNU5PakN0djEyaVVLdnQ1RGdLbUVpdnMydWhWV0ZzdFRVN3QtdXdfa19qNTd2ZDlkaUNKWFBvclJXTXdmYUtnbnV0Z0JkME9lUQ?oc=5","Fri, 02 Oct 2026 00:38:28 GMT","GT Biopharma sells USD 7.75 million: what it means for GT Biopharma stock AD HOC NEWS","AD HOC NEWS",{"title":200,"link":201,"pubDate":202,"description":203,"source":198},"GT Biopharma regains Nasdaq compliance: what it means for GT Biopharma stock - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMixwFBVV95cUxPU3g0NXZkblBfVnlaQ094aVdhOWhYNDNnY19HVWZIbzBXTzgxSUt2aGRqbkJyazJ2MXNVckpEUVVSY0ZBRWlrbnREa0Q1Q3laYnJjX0I5Tk52Qk9QS1ZVR2lxQ0hTY3VHTkZndUFLM01NbUNfTk1jcnlLa0kyRzNyWVl4MFoyZlNpc1RqbE91bzduR1RULTAtQkVXTjExeXQ2RFNoQzBaUWVrekRCYWRiQVZfeGZWdWtmdmVjWFVGVElQeVBFV21R?oc=5","Mon, 05 Oct 2026 04:03:37 GMT","GT Biopharma regains Nasdaq compliance: what it means for GT Biopharma stock AD HOC NEWS",{"title":205,"link":206,"pubDate":207,"description":208,"source":198},"GT Biopharma stock reports USD 7.75 million financing update - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuwFBVV95cUxOYXZBLWJyOVExT2U0ZFJKVXVZQXBmbjVIYnMzZ2twSmxUck1OYmVNM0E5WUF4am8xMmpOVGFvRUZ4UXNxMExJU2xhZEhDbXBRdDVDaHNMdjh0WXpfYk1xRk9pMUFEeHJXeVJMNzRZX3pmYTkyZUh2SzVSbDcwZ201X2Z1My05cVRJbUVrc2NPUzQzZ0pXeEoya0czVkxSWXRQNWs4S3duZkJuYUpEZkQxcnJWLTFsTUVMR3U0?oc=5","Thu, 24 Sep 2026 17:22:08 GMT","GT Biopharma stock reports USD 7.75 million financing update AD HOC NEWS"]